This is a preview of subscription content, log in via an institution to check access.
Notes
2018 British pounds
Reference
Bain SC, et al. Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme. Diabetes Therapy : Jan 2019. Available from: URL: http://doi.org/10.1007/s13300-019-00736-6
Rights and permissions
About this article
Cite this article
Oral semaglutide cost effective for T2DM in UK. PharmacoEcon Outcomes News 844, 27 (2020). https://doi.org/10.1007/s40274-020-6490-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6490-5